Rajan Sudarsan, Ahmed Rafeeq P H, Jagatheesan Ganapathy, Petrashevskaya Natalia, Boivin Greg P, Urboniene Dalia, Arteaga Grace M, Wolska Beata M, Solaro R John, Liggett Stephen B, Wieczorek David F
Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati Medical Center, Cincinnati, OH 45267-0524, USA.
Circ Res. 2007 Jul 20;101(2):205-14. doi: 10.1161/CIRCRESAHA.107.148379. Epub 2007 Jun 7.
Mutations in striated muscle alpha-tropomyosin (alpha-TM), an essential thin filament protein, cause both dilated cardiomyopathy (DCM) and familial hypertrophic cardiomyopathy. Two distinct point mutations within alpha-tropomyosin are associated with the development of DCM in humans: Glu40Lys and Glu54Lys. To investigate the functional consequences of alpha-TM mutations associated with DCM, we generated transgenic mice that express mutant alpha-TM (Glu54Lys) in the adult heart. Results showed that an increase in transgenic protein expression led to a reciprocal decrease in endogenous alpha-TM levels, with total myofilament TM protein levels remaining unaltered. Histological and morphological analyses revealed development of DCM with progression to heart failure and frequently death by 6 months. Echocardiographic analyses confirmed the dilated phenotype of the heart with a significant decrease in the left ventricular fractional shortening. Work-performing heart analyses showed significantly impaired systolic, and diastolic functions and the force measurements of cardiac myofibers revealed that the myofilaments had significantly decreased Ca(2+) sensitivity and tension generation. Real-time RT-PCR quantification demonstrated an increased expression of beta-myosin heavy chain, brain natriuretic peptide, and skeletal actin and a decreased expression of the Ca(2+) handling proteins sarcoplasmic reticulum Ca(2+)-ATPase and ryanodine receptor. Furthermore, our study also indicates that the alpha-TM54 mutation decreases tropomyosin flexibility, which may influence actin binding and myofilament Ca(2+) sensitivity. The pathological and physiological phenotypes exhibited by these mice are consistent with those seen in human DCM and heart failure. As such, this is the first mouse model in which a mutation in a sarcomeric thin filament protein, specifically TM, leads to DCM.
横纹肌α-原肌球蛋白(α-TM)是一种重要的细肌丝蛋白,其突变可导致扩张型心肌病(DCM)和家族性肥厚型心肌病。α-原肌球蛋白内的两种不同点突变与人类DCM的发生有关:Glu40Lys和Glu54Lys。为了研究与DCM相关的α-TM突变的功能后果,我们生成了在成年心脏中表达突变型α-TM(Glu54Lys)的转基因小鼠。结果表明,转基因蛋白表达的增加导致内源性α-TM水平的相应降低,而肌丝TM总蛋白水平保持不变。组织学和形态学分析显示,DCM发展并进展为心力衰竭,6个月时经常死亡。超声心动图分析证实了心脏的扩张表型,左心室缩短分数显著降低。心脏做功分析显示收缩和舒张功能显著受损,心肌纤维的力测量显示肌丝的Ca(2+)敏感性和张力产生显著降低。实时RT-PCR定量分析显示β-肌球蛋白重链、脑钠肽和骨骼肌肌动蛋白的表达增加,而Ca(2+)处理蛋白肌浆网Ca(2+)-ATP酶和兰尼碱受体的表达降低。此外,我们的研究还表明,α-TM54突变降低了原肌球蛋白的柔韧性,这可能会影响肌动蛋白结合和肌丝Ca(2+)敏感性。这些小鼠表现出的病理和生理表型与人类DCM和心力衰竭中所见的一致。因此,这是第一个由肌节细肌丝蛋白(特别是TM)突变导致DCM的小鼠模型。